Murphy & Mullick Capital Management Corp

Position in CRSP — CRISPR Therapeutics AG

CIK 2047271 SMITHTOWN, NY

Position in CRSP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,544

-$1,257 QoQ

Shares Held

120

-26.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#411

of 519 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Murphy & Mullick Capital Management Corp holds $1,730,688 across 5 Biotechnology names. CRSP ranks #4 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,143	$1,561,222
2	REGN	Regeneron Pharmaceuticals, Inc.	240	$149,649
3	MRNA	Moderna, Inc.	139	$9,734
4	CRSP	CRISPR Therapeutics AG This page	120	$6,544
5	ROIV	Roivant Sciences Ltd.	100	$3,539

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,544	120	-26.8%	Shares	Sole	2026-08-14
2026-03-31	$7,801	164	-42.5%	Shares	Sole	2026-04-17
2025-12-31	$14,945	285	0.0%	Shares	Sole	2026-02-10
2025-09-30	$18,470	285	0.0%	Shares	Sole	2025-11-07
2025-06-30	$13,862	285	+51.6%	Shares	Sole	2025-08-14
2025-03-31	$6,397	188	0.0%	Shares	Sole	2025-05-14
2024-12-31	$7,399	188	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.